Trade

with

NeuroMetrix Inc
(NASDAQ: NURO)
AdChoices
1.74
+0.02
+1.16%
After Hours :
-
-
-

Open

1.73

Previous Close

1.72

Volume (Avg)

46.38k (99.76k)

Day's Range

1.71-1.79

52Wk Range

1.47-4.25

Market Cap.

13.82M

Dividend Rate ( Yield )

-

Beta

1.10

Shares Outstanding

7.94M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 5.28M

    • Net Income

    • -8.02M

    • Market Cap.

    • 13.82M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -144.94

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.10

    • Forward P/E

    • -1.74

    • Price/Sales

    • 1.53

    • Price/Book Value

    • 1.82

    • Price/Cash flow

    • -1.30

      • EBITDA

      • -7.21M

      • Return on Capital %

      • -58.30

      • Return on Equity %

      • -111.24

      • Return on Assets %

      • -58.30

      • Book Value/Share

      • 0.96

      • Shares Outstanding

      • 7.94M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 5.40 (3/28/2007)

      • Dividend Declaration Date

      • 3/14/2007

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 6.30

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.80

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • -29.87

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 55.61

            • 52.83

            • Pre-Tax Margin

            • -144.94

            • 15.96

            • Net Profit Margin

            • -144.94

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 57.20

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -109.40

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 6.40

              • 1.97

              • Quick Ratio

              • 6.00

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 2.02

              • 2.38

              • Book Value/Share

              • 0.96

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.05

                • 35.34

                • P/E Ratio 5-Year High

                • -68.75

                • 279.76

                • P/E Ratio 5-Year Low

                • -0.89

                • 148.87

                • Price/Sales Ratio

                • 1.53

                • 3.28

                • Price/Book Value

                • 1.82

                • 4.08

                • Price/Cash Flow Ratio

                • -1.30

                • 16.98

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 0.00

                    • Dividend Date

                    • 3/14/2007

                    • Ex-Dividend Date

                    • 3/28/2007

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -111.24

                        (-73.20)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • -58.30

                        (-58.70)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • -111.24

                        (-73.00)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • -

                      • 25.65k

                      • Inventory Turnover

                      • 3.53

                      • 2.66

                      • Asset Turnover

                      • 0.40

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -7.36M
                      Operating Margin
                      -139.40
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -1.30
                      Ownership

                      Institutional Ownership

                      8.92%

                      Top 10 Institutions

                      10.48%

                      Mutual Fund Ownership

                      0.28%

                      Float

                      97.76%

                      5% / Insider Ownership

                      11.45%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Extended Market Index Fund

                      •  

                        17,183

                      • 0.00

                      • 0.22

                      • Master Extended Market Index Series

                      •  

                        2,033

                      • 0.00

                      • 0.03

                      • USAA Extended Market Index Fund

                      •  

                        2,032

                      • -0.05

                      • 0.03

                      • The Vanguard - Total Stk Mkt Idx Trust. CF

                      •  

                        738

                      • 0.00

                      • 0.01

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        685

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BlackRock Fund Advisors

                      •  

                        425,906

                      • +7.64%

                      • 6.30

                      • NEA Management Company, LLC

                      •  

                        57,273

                      • 0.00%

                      • 0.85

                      • Vanguard Group, Inc.

                      •  

                        13,921

                      • 0.00%

                      • 0.21

                      • BlackRock Advisors LLC

                      •  

                        2,033

                      • 0.00%

                      • 0.03

                      • Fidelity Management & Research Company

                      •  

                        685

                      • 0.00%

                      • 0.01

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Distressed

                      Style

                      Small Value

                      NeuroMetrix Inc was incorporated in Delaware in June 1996. The Company is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company develops and markets neurodiagnostic...more systems which consist of a medical device plus single patient-use biosensors or electrodes. Other accessories are also offered to its customers. The Company’s product portfolio includes NC-stat DPN check for Diabetes Diagnostics; Sensus for Pain Management and Advance NCS/EMG System for Orthopedics & Neurology. NC-stat DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as DPN. It is designed to be used by primary care physicians, endocrinologists, podiatrists and other clinicians at the point-of-care ...moreto objectively detect, stage, and monitor DPN. The device measures nerve conduction velocity and response amplitude of the sural nerve, a nerve in the lower leg and ankle. These parameters are recognized as sensitive and specific biomarkers of DPN. The Company also markets a medical device, which has been cleared by the FDA and which is used for the assessment of neuropathies such as carpal tunnel syndrome, diabetes, and sciatica. Its ADVANCE™ NCS/EMG System, or the ADVANCE System, which is a part of its legacy neurodiagnostics business, is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures. Its ADVANCE System is comprised of; various types of electrodes and needles, its ADVANCE device and related modules, and a communication hub that enables the physician’s office to network their device to its servers for data archiving, report generation and other network services. The Company competes with CareFusion Corporation, Cadwell Laboratories, Inc., and Natus Medical Incorporated. The Company’s products are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act, or FDCA, and the regulations promulgated thereunder, as well as by other regulatory bodies in the United States and abroad.lessless

                      Key People

                      Dr. Shai N. Gozani,M.D.,PhD

                      CEO/Chairman of the Board/Director/President/Secretary/Founder

                      Thomas T. Higgins

                      CFO/Chief Accounting Officer/Senior VP/Treasurer

                      Timothy R. Surgenor

                      Director

                      Dr. Allen J. Hinkle,M.D.

                      Director

                      Dr. David E. Goodman,M.D.

                      Director

                      • NeuroMetrix Inc

                      • 62 Fourth Avenue

                      • Waltham, MA 02451

                      • USA.Map

                      • Phone: +1 781 890-9989

                      • Fax: -

                      • neurometrix.com

                      Incorporated

                      1996

                      Employees

                      30

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: